Healthcare, Advanced Analytics, SAS, Decision-making and data modeling

LEHAR ZAIDI

Cell: 305-***-**** **********@*****.***

Highly experienced thought-leader, epidemiologist and clinical analytics professional with fourteen years’ experience in life sciences, biostatistics and advanced data analytics. Two graduate degrees including, Biosciences (MS, Biochemical Engineering) and MPH (Epidemiology), with over 5 years of SAS expertise in the pharmaceutical trials sector. Strong track record of clinical research at leading US and international organizations, including NIH, Premera Blue Cross and the World Bank. Publications and presentations for international health conferences. I am seeking a stimulating position to apply my knowledge in the life sciences and biostatistics to create value for global healthcare.

SOFTWARE AND CORE COMPETENCIES

Epidemiology & Biostatistics: SAS, SQL, R languages; Proportional hazard models; Strategy region and tornado charts; Linear and Non-linear regression; Decision trees; ROC curves; Time-series analysis and Forecasting; Hypothesis testing, sample size and Confidence interval estimation; Bayesian GSEA

Advanced analytics and Decision-making: Probability and decision-making under uncertainty; StatTools, @Risk simulations, PrecisionTree, Solver Table, Optimization and Simulation, Data Sampling and survey techniques

HEDIS, CDISC Data Standards: Tableau-based clinical dashboards; MedDRA, CRFs and CDE (Common Data Elements); Adverse Drug Events tools; Drug Safety and Efficacy; LOINC codes (Lab data), SDTM standards, BRIDG, TAUG standards (Alzheimers, Schizophrenia), CDASH and ADaM

Oncology, Genetics and Infectious Diseases: Breast cancer biomarkers, Virology and Bacteriology; Lymphoma retrospective studies; R-based Bioconductor group at the Fred Hutchinson Cancer Research Center

Product and Data management: ETL and Data Quality Control; integrating medical, Rx, Lab data

Posters and presentations at international health conferences, including Harvard Medical School, UC Davis and the University of Alabama at Birmingham

QUALIFICATIONS

Master’s in Public Health (M.P.H), Epidemiology December 2006

University of Alabama at Birmingham, School of Public Health Birmingham, AL

Courses: Biostatistics, SAS, Cancer and Infectious Disease Epidemiology, Pharmaco-epidemiology, Immunology, Global Health,

M.S. Biochemical Engineering June 1997

School of Chemical Engineering, University of Birmingham Birmingham, UK

Courses: Genetics, Biopharmaceutical Development, Bio-Process Engineering, Molecular Biology

University of Delhi New Delhi, India

B.S. with Honors, Microbiology May 1994 Courses: Biochemistry, Bacteriology, Virology, Immunology, Genetics and Biotechnology

CERTIFICATES AND AWARDS

Certificate in SAS, University of Alabama at Birmingham, School of Public Health 2007

Premera Blue Cross: Nominee for the ‘Spirit of Excellence’ Award, 2011 2011

Stanford University, Continuing Education Certificate: ‘Breast Cancer Biomarkers’ 2008

Harvard Medical School, Poster & Continuing Education Certificate: ‘Cohort study on ICU mortality’ 2007

Outstanding Performance Certificate: REGARDS Stroke Study, University of Alabama, Birmingham 2006

PROFESSIONAL EXPERIENCE

Health and Life Sciences Analytics Company West Hartford, CT, USA

Director, Health Analytics October 2013-Present

Developed and managed SAAS-based clinical solutions applying Agile methods: Tableau-based drug efficacy dashboards, Sensitivity analysis and @ Risk based simulations for Drug safety and efficacy

Quality Improvement and Performance Measurement: Value-based health care reports including, HEDIS and AHRQ Quality metrics, Decision trees. Application of EMRS, Medical, Lab, CRF and Rx claims, including CPT, ICD-9/10 and LOINC codes, EDCs; develop TDD-based, SAAS solutions for providers and life science clients

Supported clinical study RFPs and trials including:

oProtocol development and identify potential trial candidates for ‘Progress of Mild Alzheimer's Disease in Participants on Treatment Drug X Versus Placebo’, using CRF based data and MedDRA standards

oEffectiveness and Safety study to assess the impact of two chemotherapeutic agents for Leukemias: CLL (Chronic Lymphocytic Leukemia) and MCL (Mantle Cell Leukemia), using MedDRA standards

oClinical opportunity analysis, cohort study to identify high cost patients on prescription opioids, and their comparison with non-opioid control arm. Identify target populations who would benefit from Urine Drug Monitoring (UDM) interventions.

Engagement Lead: Successfully managed 5 leading SAAS clients in the life-science and hospital-provider segments, integrating SLAs, Agile driven deliverables, coordinating deadlines

QC and Data Management: Improved organizational data quality for DDD and TDD solutions, for integrated Rx, Lab, Medical data from clients

Premera Blue Cross Mount Lake Terrace

Senior Statistical Analyst, Health Care Economics November 2010-April 2013

Nominated for the ‘Spirit of Excellence’ award, 2011

Contributed to organizational cost-savings and member risk-assessment for DDD-based solutions: Predictive models and propensity risk scores for Oncology and Chronic diseases; Tableau-based Opportunity Analysis reports, applying Bayesian CE models; Longitudinal models for Inpatient Outcomes, MSB drug models to identify high-cost drugs

Developed HEDIS, performance measurement and care-management reports applying clinical data standards, including CDISC’s LOINC codes, TAUG standards for Asthma, AHRQ (Agency for Healthcare Research& Quality), PSIs using EMRs and claims data. worked in collaboration with physicians, bio-statisticians and pharmacologists

Premera Blue Cross (K-Force consultant) Mount Lake Terrace, WA

Senior Statistical Analyst, Clinical Performance Management May 2010- November 2010

Same as above

Group Health Cooperative (K-Force consultant) Seattle, WA

Senior Measurement Consultant, Enterprise Information Management August-October 2009

Conducted retrospective cohort studies, on geographic and provider-specific variation in hysterectomies in Washington state, used CPT, LOINC and EPIC data

Presented reports using panel plots, bar charts and histograms for the EIM division

Veratect Corporation Kirkland-Seattle, WA

Senior Regional Analyst, South Asia November 2008-March 2009

Developed bio-surveillance reports by applying Spatial statistics for avian flu, polio and meningitis, yellow fever and other global health diseases

Leveraged expertise in genomics, viral and bacterial mutation to report on disease outbreaks, etiology and severity

California Primary Care Association (Consultancy) Sacramento, CA

Epidemiologist February-April 2008

Supported HEOR and clinical analysis for California’s diabetes reduction AQIC program (Accelerating Quality Improvement through Collaboration)

Applied CDISC standards, including LOINC codes, HCPCS and CPT codes to develop quality measures for populations stratified by gender, SES, geographic location

Outcome Sciences, Inc. Cambridge, MA

Senior Associate, Scientific Affairs June 2007-October 2007

Conducted Comparative Effectiveness studies, applying PICO frameworks & evidence synthesis for Phase-IV and post-marketing drugs

Applied CDISC data standards, GCP-ICH guidelines; used Scatter plots and Likelihood functions; conducted case-control studies and patient registry data analysis for the Scientific Affairs department

University of Alabama at Birmingham (UAB) Birmingham, AL

Clinical Research Associate and Graduate Assistant September 2005-March 2007

UAB School of Medicine-Medtronic

Conducted analysis for Phase-3 trials for Medtronic cardiac device for Congestive Heart Failure patients, applying CDISC standards (SDTMIG-MD); reported Relative Risk ratios in the treatment and control arms

UAB-National Institute of Mental Health (NIMH)

Conducted research for NIMH drug safety study: ‘Weight gain and diabetes among persons treated with atypical antipsychotics, mood stabilizers, and/or SSRIs with schizophrenia spectrum disorders’; analyzed DSM-IV and ICD-9 codes, LOINC Lab codes, sourced from EMRs

Developed retrospective cohort study and Mixed-effects models to support the hypothesis

Department of Biostatistics-National Institute of Health (NIH)

Awarded ‘Merit Certificate for Outstanding performance’, in the NIH ‘REGARDS Stroke study’ (Regional and Geographic Differences in Stroke)

Contributed to the Stroke study’s IRB requirements: enrolled new eligible patients, collected core CDE data, updated forms using Oracle Clinical software

United States Agency for International Development (USAID); Voluntary Health Association of India; Indicus Analytics; School of Community and Social Medicine, Jawaharlal Nehru University New Delhi, India

Senior Consultant December 2001 – May 2005

Conducted HEOR research for the European Union’s (EU) report, ‘Adverse Effects of HIV/ AIDS Anti-retroviral drugs’ (cited: India Development and Participation. Sen, Amartya et al. Cambridge, UK, 2004).

Collected Vaccination program data and developed clinical reports for USAID’s Environmental Health Project (EHP) on child immunization and nutrition

Developed analytics reports for the World Bank’s report on ‘Economic Costs of Malnutrition in India’ (cited: India's Undernourished Children. Gragnolati, M. et al. World Bank Human Development Network. 2004).

Interim Technology and Pentacom Communications Ltd Chicago, USA; London, UK

Management Consultant October 1997- May 2000

Conducted vendor coordination and user testing with internet-based tools for healthcare and other clients; Wrote papers on the impact of the Internet on different industries for the Financial Times, the Guardian and the MBA Career Guide.

PAPERS AND PRESENTATIONS

Harvard Medical School, ‘Disparities in ICU (Intensive Care Unit) and Surgical Outcomes’ 2007

School of Medicine, University of California, Davis: ‘HIV/AIDS programs in India’ 2006

World Bank’s report on ‘Economic Costs of Malnutrition in India’ co-authored with Bhandari L.cited: India's Undernourished Children. Gragnolati, M. et al. 2004

The Guardian and The Financial Times, UK 1997

PROFESSIONAL MEMBERSHIPS

Association of Clinical Research Professionals (ACRP)

INTERESTS AND ACTIVITIES

Writing, travelling, environmental preservation, women’s health

Contact this candidate